VAERS reports by lot

GSK Hepatitis A lot NT9X3: VAERS reports

28 VAERS reports list lot NT9X3 as a GSK Hepatitis A vaccine, received between 2022-10-31 and 2024-12-11. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
28
Reports
0%
Marked serious
0
With a death outcome
16
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)436%
Neurological218%
Allergic / Anaphylactic19%
Gastrointestinal19%
Dermatological (non-injection-site)19%
Psychiatric / Neuropsychiatric19%
Injection-site / Local reaction19%

Where reports came from

U.S. state of the reporter, where given (top 12).

North Carolina3
Michigan3
Illinois2
Minnesota2
Nebraska2
Texas2
New York2
Puerto Rico1
Washington1
Maryland1
New Hampshire1
Virginia1

Reports by month received

2022-101
2022-113
2022-122
2023-012
2023-021
2023-033
2023-052
2023-061
2023-071
2023-091
2023-101
2024-012
2024-041
2024-081
2024-094
2024-122

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.